ArticleMolecular cancer therapeutics2020

Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.

Chevaun D Morrison-Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.